Interestingly, the number of CD8+ Vβ3 T cells decreased in the tumors following C4, while CD4+ T-cell numbers remained stable, possibly due to cell death of the CD8+ Vβ3 T cells in the TME following serial activation and tumor engagement. This evidence concerns the gene CD8A and neoplasm.